National Academies of Sciences%2c Engineering%2c and Medicine: Evolution of Translational Omics: Lessons Learned and the Path Forward
The rapid evolution of high-throughput sequencing and mass spectrometry has positioned clinical multi-omics at the forefront of modern laboratory medicine. By analyzing multiple biological layers ...
On January 13th and 14th 2022, the Center for Translational Cancer Research organized the virtual third Indian Cancer Genome Atlas (ICGA) Conference 2022 “Biobanking to Omics – Collecting the Global ...
A report issued last week by the Institute of Medicine (IOM) calls on the US Food and Drug Administration (FDA) to become involved in the development of so-called "omics"-genomics, proteomics, ...
GEN: IOM Guidelines for Use of Omics Tests in Clinical Trials Add Rigor to Quality Assurance
IOM Guidelines for Use of Omics Tests in Clinical Trials Add Rigor to Quality Assurance
Seeking Alpha: Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research
Strategic partnership between Mission Bio and Fulgent Genetics (FLGT) will enable drug developers to leverage single-cell multi-omics for biomarker discovery, clinical research, and single-cell MRD ...
Mission Bio Partners with Fulgent Genetics to Broaden Accessibility of Single-Cell Multi-Omics for Drug Development and Clinical Research
Frontiers: NAM‑informed quantitative systems pharmacology: Advancing human‑relevant modeling for translational cancer immunotherapy
The field of cancer immunotherapy and immunology is rapidly reshaping modern oncology, yet the translational gap between mechanistic discoveries and durable ...
ascopubs.org: Proceedings of the 3rd Indian Cancer Genome Atlas Conference 2022: Biobanking to Omics: Collecting the Global Experience
Proceedings of the 3rd Indian Cancer Genome Atlas Conference 2022: Biobanking to Omics: Collecting the Global Experience